NCT04778163

The Use of Humor With Young Adults in Psychiatric Care

Completed NA Last updated 1 November 2022

What this trial tests

NA trial testing Clinical use of humor in Treatment Adherence and Compliance in 34 participants. Completed in 31 October 2022.

Timeline

19 September 2019

Primary endpoint
30 June 2022

31 October 2022

Quick facts

Lead sponsor	University Hospital, Geneva
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	34
Start date	19 September 2019
Primary completion	30 June 2022
Estimated completion	31 October 2022
Sites	1 location across Switzerland

Drugs / interventions tested

• Clinical use of humor

Conditions studied

• Treatment Adherence and Compliance — all drugs for Treatment Adherence and Compliance →
• Psychiatric Disorder — all drugs for Psychiatric Disorder →

Sponsor

University Hospital, Geneva

Who can join

Adults 18 to 25, any sex, with Treatment Adherence and Compliance or Psychiatric Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks.

The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being.

Group 1 (test group) will participate in the humor-based sessions, while Group 2 (control group) will receive regular treatment for 6 weeks (waiting list: patients in Group 2 will attend humor-based sessions once Group 1 has completed their 6 weeks).

At the end of the 6-week sessions, both groups will receive the same series of pre-session tests to see whether or not there has been improvement in their overall functioning, psychiatric symptomatology and appreciation/use of humor.

At the end of the 2x 6-week sessions, group 2 will again receive this series of pre-session tests to see whether or not their overall functioning, psychiatric symptomatology and appreciation/use of humour has improved.

Objective(s)/Aim:

To evaluate the resilience of young adult psychiatric patients and their ability to cope with stress through the use of humor in a set of 6 modules on the use of humor.

To evaluate the symptoms.

Outcome/Endpoints :

Using scales, measure this evolution.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.